| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 23rd, 2004 | 18 | Yes |
Popular Name: Sulfamerazine Sulfamerazine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 127-58-2 , 127-79-7 , 723-46-6 , [127-79-7] , [723-46-6]
(p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin
(p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin [German]
127-79-7; D02435; Sulfamerazine (INN)
127-79-7; Prestwick_17; Sulfamerazine
2(p-Aminobenzolsulfonamido)-4-methylpyrimidin
2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine
2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine
2-(Sulfanilamido)-4-methylpyrimidine
2-Sulfanilamido-4-methylpyrimidine
2-Sulfanilamido-4-methylpyrimidine
4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide
4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide (9CI)
4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
4-Amino-N-(4-methyl-pyrimidin-2-yl)-benzenesulfonamide
4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide
4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide
4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide; sodium
5-25-10-00167 (Beilstein Handbook Reference)
Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-
C11H12N4O2S.C10H10N4O2S; LS-178651; SULFADIAZINE; SULFAMERAZINE; SULFONAMIDES DUPLEX
N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide
N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide
N(sup1)-(4-Methyl-2-pyrimidinyl)sulfanilamide
N-(4-Methyl-2-pyrimidyl)sulfanilamide
N1-(4-Methyl-2-pyrimidinyl)sulfanilamide
N1-(4-Methylpyrimidin-2-yl)sulfanilamide
N1-(5-Methylisoxazol-3-yl)-4-aminobenzene-1-sulfonamide
sulfamerazina; sulfamerazine; sulfamerazinum
Sulfamerazine (Trisulfapyrimidines) (FDA); Sulfamerazine (BAN
Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-
Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-
Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)- (8CI)
USP); Sulfamerazine (Trisulfapyrimidines) (FDA); Sulfamerazine Sodium [Injection] (INN
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 0.40 | 2.61 | -55.27 | 2 | 6 | -1 | 100 | 263.302 | 3 | ↓ |
| Mid Mid (pH 6-8) | 0.40 | 2.91 | -13.65 | 3 | 6 | 0 | 98 | 264.31 | 3 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| mechanism | Folic acid biosynthesis antagonist | ZereneX Building Blocks |
| Molecular_Solubility | 2.514 | Bitter DB |
| Melting_Point | 234-238? | Alfa-Aesar |
| Melting_Point | 234-238° | Alfa-Aesar |
| ALOGPS_SOLUBILITY | 3.04e-01 g/l | DrugBank-approved |
| Purity | 98% | Fluorochem |
| Therapy | antibacterial | SMDC Iconix |
| Target | Antifection | Selleck Chemicals |
| biological_use | Antiseptic | IBScreen Bioactives |
| mechanism | Folic acid biosynthesis antagonist | IBScreen Bioactives |
| Target | Others | Selleck Chemicals |
